Objectives
In this webinar, key experts in the field will discuss the significance of the NEW real-world evidence data across classes for clinical practice. They will present the latest findings related to IL-17i/ ixekizumab and other classes in patients with Psoriatic Arthritis. Additionally, they will review how PsA patients are treated in real-world, and a real clinical case with ixekizumab will be discussed which reviews the impact of these findings.
This Course For :
Physician
( Family Medicine , Internal Medicine , Rheumatology )
Resident / Fellow
( Family Medicine , Internal Medicine , Rheumatology )
Speaker
Prof. Ennio Lubrano
Professor of Rheumatology at the Department of Medicine and
Health Sciences of the University of Molise, Campobasso, Italy
Dr. Nicola Gullick
Consultant Rheumatologist at University Hospitals Coventry and
Warwickshire, United Kingdom
Prof. Jacques Morel
Head of Rheumatology Department, Lapeyronie Hospital CHU
Montpellier, University of Montpellier, Montpellier, France
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
16 Oct 2024 To 16 Oct 2024 -
08:30 PM To 09:30 PM 
Certificate Available 
Online
- 215
Add to Calendar
10/16/2024 08:30 PM
10/16/2024 09:30 PM
Asia/ Riyadh
Navigating Real-World Effectiveness Beyond Clinical Trials in Psoriatic Arthritis
Navigating Real-World Effectiveness Beyond Clinical Trials in Psoriatic Arthritis
https://medicalacademy.org/portal/event/view/2250
